Baltimore, MD, United States of America

Yasin A Khan

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Johns Hopkins University. Active years: 2014-2024.

USPTO Granted Patents = 5 

% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 62(Granted Patents)


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations of Yasin A Khan in Eye Therapeutics

Introduction

Yasin A Khan is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of eye therapeutics. With a total of five patents to his name, he has made significant strides in developing innovative drug delivery systems aimed at treating eye disorders.

Latest Patents

Among his latest patents is a groundbreaking invention focused on the sustained delivery of therapeutic agents to an eye compartment. This patent outlines compositions and methods for treating eye disorders by administering a drug delivery system that contains a particle with a core and a specialized coating. The coating can be covalently or non-covalently associated with the particle, presenting a hydrophilic region to the surrounding environment. This innovative approach aims to reduce inflammation or intraocular pressure (IOP) after administration, demonstrating a marked improvement over traditional uncoated particle systems.

Career Highlights

Yasin A Khan is affiliated with The Johns Hopkins University, where he continues to advance research in ocular therapeutics. His work is characterized by a commitment to improving patient outcomes through innovative drug delivery methods.

Collaborations

He collaborates with esteemed colleagues such as Peter John McDonnell and Samuel K Lai, contributing to a rich environment of research and innovation.

Conclusion

Yasin A Khan's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of eye disorders. His patents reflect a dedication to enhancing therapeutic delivery systems, ultimately benefiting patients in need of effective eye care solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…